Primary cutaneous CD30-positive T-cell proliferations are a group of lymphoproliferative disorders characterized by the proliferation of CD30-positive T-cells in the skin. These conditions can manifest as solitary or multiple lesions and may resemble other skin disorders. Accurate coding with ICD-10 Code C86.6 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.
ICD-10 Code C86.6 represents Primary cutaneous CD30-positive T-cell proliferations, which are neoplastic conditions involving the skin. This code should be used when documenting cases of cutaneous lymphoproliferative disorders that exhibit CD30 positivity. It is crucial for accurate clinical documentation and billing, particularly in cases where these conditions may lead to complications or require specialized treatment.
Primary cutaneous CD30-positive T-cell proliferations are primarily caused by the abnormal proliferation of T-cells expressing the CD30 antigen. These conditions can progress to more severe forms if left untreated, necessitating medical intervention. Early diagnosis and treatment are vital to prevent complications and improve patient outcomes.
ICD-10 Code C86.6 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Primary cutaneous CD30-positive T-cell proliferations. This code aids in capturing the patient's symptoms, guiding clinical decision-making, and ensuring appropriate billing in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C86.6 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Primary cutaneous CD30-positive T-cell proliferations. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Primary cutaneous CD30-positive T-cell proliferations may require hospitalization in cases of severe manifestations or complications. Treatment approaches are tailored to the individual patient's condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.6 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 11100 | Biopsy of skin, first lesion. |
| 96900 | Phototherapy for skin conditions. |
| 99213 | Established patient office visit, level 3. |
Common Questions About Using ICD-10 Code C86.6 for Primary cutaneous CD30-positive T-cell proliferations
What are the common symptoms of Primary cutaneous CD30-positive T-cell proliferations?
Common symptoms include the appearance of solitary or multiple erythematous nodules or plaques on the skin, which may be itchy or bleed. Patients may also report changes in existing skin lesions.
How is Primary cutaneous CD30-positive T-cell proliferation diagnosed?
Diagnosis is typically made through a combination of clinical examination and histological analysis, confirming the presence of CD30-positive T-cells in skin biopsies.
What treatment options are available for this condition?
Treatment options include topical corticosteroids, phototherapy, and systemic therapies for more extensive disease. Management is tailored to the individual patient's condition.
Is hospitalization required for patients with this condition?
Hospitalization may be necessary for patients with severe manifestations or complications. Treatment approaches are determined based on the severity of the condition.
Clinical Notes
SOAP notes
DAP notes
AI medical notes